After trading hours yesterday, an FDA Advisory panel unanimously approved a novel approach to treating asthma, a disease that affects millions of people worldwide. Genentech (DNA), Novartis (NOV), and the small biotech
The post FDA Panel Decision Is Good For These Three Stocks appeared first on TradingMarkets.com.